However, normal cell radiosensitivity in some cases may be an important factor predictive of radiation therapy response as illustrated by West et al (2001) whose results showed that blood lymphocyte radiosensitivity (SF2) is a highly significant prognostic factor for the risk of developing late radiation morbidity.
← all excerpts
Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment.
1
—
—